Adpaxil 260mg/43.4ml Injection
Marketer
Adley Formulations
Salt Composition
Paclitaxel (6mg/ml)
Overview Adpaxil 260mg/43.4ml Injection
Oncaspar 260mg/43.4ml Injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects, such as edema (hands, face), alopecia, and weight increase, are possible. Concomitant medications may be prescribed to mitigate these effects. Report unusual bruising/bleeding, sore throat, mouth sores, or fever promptly. This medication can suppress blood cell production (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood counts and liver function are essential. Inform your doctor of pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives, before commencing treatment. Interactions with other medications are possible; provide a complete medication list to your physician. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Adpaxil 260mg/43.4ml Injection
Cancers of the breast, lung (non-small cell), and pancreas
Major Benefits of Adpaxil 260mg/43.4ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Adpaxil 260mg/43.4ml Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Adpaxil 260mg/43.4ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Adpaxil 260mg/43.4ml Injection works:
Oncaspar 260mg/43.4ml Injection is a cancer treatment. Its mechanism involves disrupting microtubule networks, essential for cancer cell division and proliferation. This inhibits cancerous growth, leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Adpaxil 260mg/43.4ml Injection is not safe.
PregnancyCONSULT YOUR DOCTOR
Administering Adpaxil Injection (260mg/43.4ml) during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Adpaxil 260mg/43.4ml Injection is contraindicated while breastfeeding due to potential infant toxicity. Research indicates a risk of harmful effects on the nursing infant.
DrivingUNSAFE
The injectable formulation of Adpaxil (260mg/43.4ml) may induce adverse reactions that could impair driving ability. While there's no inherent prohibition against driving between treatment cycles, the presence of alcohol in this medication suggests caution regarding operating a vehicle.
KidneySAFE IF PRESCRIBED
Adpaxil Injection (260mg/43.4ml) is considered safe for patients with kidney disease; dosage modification is not typically necessary. Nevertheless, consultation with a physician is advised if you have pre-existing renal impairment.
LiverCAUTION
Adpaxil 260mg/43.4ml Injection requires careful administration in individuals with hepatic impairment. Dosage modification of Adpaxil 260mg/43.4ml Injection may be necessary. Physician consultation is advised. Adpaxil 260mg/43.4ml Injection is contraindicated for patients exhibiting severe liver dysfunction.
What if you forget to take Adpaxil 260mg/43.4ml Injection :
NA
Facts to Know About Adpaxil 260mg/43.4ml Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based medications |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapeutics |
| Mechanism of Action | Microtubule-disrupting drugs: Taxane class |
3,018 People bought this recently